Terms: = Germ cell tumor AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE AND Treatment
83 results:
1. Inhibition of Autophagy Aggravates
Tsai CH; Huang HC; Lin KJ; Liu JM; Chen GL; Yeh YH; Lu TL; Lin HW; Lu MT; Chu PC
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279345
[TBL] [Abstract] [Full Text] [Related]
2. Comparison of HASTE versus EPI-Based DWI for Retinoblastoma and Correlation with Prognostic Histopathologic Parameters.
Sharma M; Gupta A; Jana M; Kashyap S; Bakhshi S; Sharma S
AJNR Am J Neuroradiol; 2024 Feb; 45(2):198-204. PubMed ID: 38176729
[TBL] [Abstract] [Full Text] [Related]
3. Comprehensive molecular findings in primary malignant melanoma of the esophagus: A multicenter study.
Deng L; Wang HY; Hu CF; Liu XY; Jiang K; Yong JJ; Wu XY; Guo KH; Wang F
Pigment Cell Melanoma Res; 2024 May; 37(3):363-371. PubMed ID: 38158377
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic model for assessing the human glioma cell malignancy grade based on MDM2, MELK, SOX2, CDK4, DR5 and OCT4 gene expression.
Tyagunova EE; Drozd SF; Kalennik OV; Samoylenkova NS; Savchenko EA; Danilov GV; Pavlova GV
Zh Vopr Neirokhir Im N N Burdenko; 2023; 87(6):43-51. PubMed ID: 38054226
[TBL] [Abstract] [Full Text] [Related]
5. Retinoblastoma in Asia: Clinical Presentation and treatment Outcomes in 2112 Patients from 33 Countries.
Kaliki S; Vempuluru VS; Mohamed A; Al-Jadiry MF; Bowman R; Chawla B; Hamid SA; Ji X; Kapelushnik N; Kebudi R; Sthapit PR; Rojanaporn D; Sitorus RS; Yousef YA; Fabian ID;
Ophthalmology; 2024 Apr; 131(4):468-477. PubMed ID: 37839559
[TBL] [Abstract] [Full Text] [Related]
6. Palbociclib releases the latent differentiation capacity of neuroblastoma cells.
Ferguson KM; Gillen SL; Chaytor L; Poon E; Marcos D; Gomez RL; Woods LM; Mykhaylechko L; Elfari L; Martins da Costa B; Jamin Y; Carroll JS; Chesler L; Ali FR; Philpott A
Dev Cell; 2023 Oct; 58(19):1967-1982.e8. PubMed ID: 37734383
[TBL] [Abstract] [Full Text] [Related]
7. A Potential Anti-Glioblastoma Compound LH20 Induces Apoptosis and Arrest of Human Glioblastoma cells via CDK4/6 Inhibition.
Wang Y; Li Y; Liu D; Zheng D; Li X; Li C; Huang C; Wang Y; Wang X; Li Q; Xu J
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446710
[TBL] [Abstract] [Full Text] [Related]
8. Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors.
Zhang F; Zhang Q; Zhu J; Yao B; Ma C; Qiao N; He S; Ye Z; Wang Y; Han R; Feng J; Wang Y; Qin Z; Ma Z; Li K; Zhang Y; Tian S; Chen Z; Tan S; Wu Y; Ran P; Wang Y; Ding C; Zhao Y
Cell Res; 2022 Dec; 32(12):1047-1067. PubMed ID: 36307579
[TBL] [Abstract] [Full Text] [Related]
9. IFN-
Jia H; Xie X; Wang L; Wang L; Che F
Comput Intell Neurosci; 2022; 2022():5492602. PubMed ID: 35814563
[TBL] [Abstract] [Full Text] [Related]
10. miR-342-3p Suppresses glioblastoma development via targeting cdk6.
Yao J; Dai Y; Liu Z; Hu W; Wan Y
Acta Biochim Pol; 2022 May; 69(2):393-397. PubMed ID: 35616621
[TBL] [Abstract] [Full Text] [Related]
11. Multi-institutional study of the frequency, genomic landscape, and outcome of IDH-mutant glioma in pediatrics.
Yeo KK; Alexandrescu S; Cotter JA; Vogelzang J; Bhave V; Li MM; Ji J; Benhamida JK; Rosenblum MK; Bale TA; Bouvier N; Kaneva K; Rosenberg T; Lim-Fat MJ; Ghosh H; Martinez M; Aguilera D; Smith A; Goldman S; Diamond EL; Gavrilovic I; MacDonald TJ; Wood MD; Nazemi KJ; Truong A; Cluster A; Ligon KL; Cole K; Bi WL; Margol AS; Karajannis MA; Wright KD
Neuro Oncol; 2023 Jan; 25(1):199-210. PubMed ID: 35604410
[TBL] [Abstract] [Full Text] [Related]
12. Genetic Markers as Predictors for Response to treatment and Possible Therapeutic Targets in Medulloblastoma.
Pérez-Pineda PL; Ortiz-Butrón R; Pérez-De Marcos JC; Hernández-Regino LM; Zapata-Tarrés MM; Torres-Espíndola LM
CNS Neurol Disord Drug Targets; 2023; 22(5):634-642. PubMed ID: 35579144
[TBL] [Abstract] [Full Text] [Related]
13. Syringic Acid Suppressed Proliferation, Invasion, and Migration via Inhibition of Matrix Metalloproteinases Expression on Glioblastoma cells by Promoting Apoptosis.
Li D; Luo D; Hu S; Zhao H; Peng B
Curr Pharm Biotechnol; 2023; 24(2):310-316. PubMed ID: 35570553
[TBL] [Abstract] [Full Text] [Related]
14. Molecular Stratification of Medulloblastoma: Clinical Outcomes and Therapeutic Interventions.
Sursal T; Ronecker JS; Dicpinigaitis AJ; Mohan AL; Tobias ME; Gandhi CD; Jhanwar-Uniyal M
Anticancer Res; 2022 May; 42(5):2225-2239. PubMed ID: 35489737
[TBL] [Abstract] [Full Text] [Related]
15. Severe blistering eruptions induced by immune checkpoint inhibitors: a multicentre international study of 32 cases.
Ingen-Housz-Oro S; Milpied B; Badrignans M; Carrera C; Elshot YS; Bensaid B; Segura S; Apalla Z; Markova A; Staumont-Sallé D; Marti-Marti I; Giavedoni P; Chua SL; Darrigade AS; Dezoteux F; Starace M; Torre AC; Riganti J; de Prost N; Lebrun-Vignes B; Bauvin O; Walsh S; Ortonne N; French LE; Sibaud V
Melanoma Res; 2022 Jun; 32(3):205-210. PubMed ID: 35377864
[TBL] [Abstract] [Full Text] [Related]
16. The RNA-Binding Protein Musashi1 Regulates a Network of cell Cycle Genes in Group 4 Medulloblastoma.
Baroni M; Guardia GDA; Lei X; Kosti A; Qiao M; Landry T; Mau K; Galante PAF; Penalva LOF
Cells; 2021 Dec; 11(1):. PubMed ID: 35011618
[TBL] [Abstract] [Full Text] [Related]
17. [Effects of tetrandrine on proliferation, migration, and invasion of glioblastoma cells].
Lu XY; Wang ZZ; Wan SC; Zhao EH; Cui HJ
Zhongguo Zhong Yao Za Zhi; 2021 Dec; 46(24):6520-6529. PubMed ID: 34994145
[TBL] [Abstract] [Full Text] [Related]
18. A Preclinical Investigation of GBM-N019 as a Potential Inhibitor of Glioblastoma via Exosomal mTOR/cdk6/STAT3 Signaling.
Wu ATH; Huang HS; Wen YT; Lawal B; Mokgautsi N; Huynh TT; Hsiao M; Wei L
Cells; 2021 Sep; 10(9):. PubMed ID: 34572040
[TBL] [Abstract] [Full Text] [Related]
19. Immunomonitoring of Stage IV Relapsed Neuroblastoma Patients Undergoing Haploidentical Hematopoietic Stem cell Transplantation and Subsequent GD2 (ch14.18/CHO) Antibody treatment.
Seitz CM; Flaadt T; Mezger M; Lang AM; Michaelis S; Katz M; Syring D; Joechner A; Rabsteyn A; Siebert N; Troschke-Meurer S; Zumpe M; Lode HN; Yang SF; Atar D; Mast AS; Scheuermann S; Heubach F; Handgretinger R; Lang P; Schlegel P
Front Immunol; 2021; 12():690467. PubMed ID: 34367149
[TBL] [Abstract] [Full Text] [Related]
20. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma.
Genovesi LA; Millar A; Tolson E; Singleton M; Hassall E; Kojic M; Brighi C; Girard E; Andradas C; Kuchibhotla M; Bhuva DD; Endersby R; Gottardo NG; Bernard A; Adolphe C; Olson JM; Taylor MD; Davis MJ; Wainwright BJ
Genome Med; 2021 Jun; 13(1):103. PubMed ID: 34154646
[TBL] [Abstract] [Full Text] [Related]
[Next]
